Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
about
G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53.Structural Studies of Pterin-Based Inhibitors of Dihydropteroate SynthaseCrystal Structure of the 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase•Dihydropteroate Synthase Bifunctional Enzyme from Francisella tularensisStructure-Based Design of Novel Pyrimido[4,5-c]pyridazine Derivatives as Dihydropteroate Synthase Inhibitors with Increased AffinityvSDC: a method to improve early recognition in virtual screening when limited experimental resources are availableInhibition of the MurA enzyme in Fusobacterium nucleatum by potential inhibitors identified through computational and in vitro approaches.A statistical framework to evaluate virtual screening.VDA, a method of choosing a better algorithm with fewer validationsResponse surface methodology in docking study of small molecule BACE-1 inhibitors.Molecular docking and analgesic studies of Erythrina variegata׳s derived phytochemicals with COX enzymes.Fragment-based drug discovery using a multidomain, parallel MD-MM/PBSA screening protocol.Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes.Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methods.Molecular docking and inhibition studies on the interactions of Bacopa monnieri's potent phytochemicals against pathogenic Staphylococcus aureus.How well do the substrates KISS the enzyme? Molecular docking program selection for feruloyl esterases.Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.Statistical analysis, optimization, and prioritization of virtual screening parameters for zinc enzymes including the anthrax toxin lethal factor.Structure-based design of novel combinatorially generated NBTIs as potential DNA gyrase inhibitors against various Staphylococcus aureus mutant strains.Challenges and advances in computational docking: 2009 in review.Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.New avenue in the treatment of temporal lobe epilepsy by classical anti-epileptics: A hypothetical establishment of executioner Caspase 3 inactivation by molecular modeling.Identification of inhibitors against α-Isopropylmalate Synthase of Mycobacterium tuberculosis using docking-MM/PBSA hybrid approach.Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent HIV-1 Protease Inhibitor.Homology modeling and virtual screening of inhibitors against TEM- and SHV-type-resistant mutants: A multilayer filtering approach.Contact-based ligand-clustering approach for the identification of active compounds in virtual screeningCluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.Virtual screening and statistical analysis in the design of new caffeine analogues molecules with potential epithelial anticancer activity.Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies.Overview of Methods and Strategies for Conducting Virtual Small Molecule Screening.Exploring the catalytic mechanism of dihydropteroate synthase: elucidating the differences between the substrate and inhibitor.Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.A Comparative QSAR Analysis, Molecular Docking and PLIF Studies of Some N-arylphenyl-2, 2-Dichloroacetamide Analogues as Anticancer Agents.Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.Integration of in vitro and in silico perspectives to explain chemical characterization, biological potential and anticancer effects of Hypericum salsugineum: A pharmacologically active source for functional drug formulations.G-quadruplex virtual drug screening: A reviewComputational Analysis and Binding Site Identification of Type III Secretion System ATPase from Pseudomonas aeruginosa
P2860
Q27313430-A8C88DFC-0245-4609-9D42-348291D5BA74Q27658109-9F4D7AB2-764B-432B-B0B9-EBCAEC217FBAQ27666288-E3C6BFC3-97B1-447A-AC36-F968F903A0A4Q27678040-9FD63926-933E-43F3-B463-443D1F880FE4Q27902311-B878354C-44C9-4642-AB82-EBDAB9F667A7Q30152646-A8684E4A-5AD3-474D-BDD0-8C8DF1312463Q33484416-2673AACE-8BB2-4B4C-AD5A-85DCF0004028Q34064348-62DF64F9-8F4A-48FA-B975-EF19AAE68001Q34267214-01B517E0-2AA6-4CF8-AD94-01D4D48ED907Q34590606-C652903C-8BB3-442B-B62F-D7BE778AD9D3Q34595676-9B4D594B-9FD4-4628-A9D3-EA63624DDACBQ35138240-E358EA44-FD63-492F-8707-3917C7FA4C1FQ35181896-A093B696-1221-46A6-A809-5D29EF6BAECCQ35276540-B6D149D2-1E25-4114-879B-359D3A726BE2Q35519541-3354173A-D4C7-4020-BFFB-1575753D93A0Q35840893-8B238B3A-2F06-472F-8EE9-528E65B65213Q36062453-510EF7D7-5B18-41E5-9448-8144E8C3991FQ36243872-02FC26E7-E1D8-4DB8-BDE9-9C829A8DFBF9Q36394817-8DCF0840-8981-4169-BF27-78522743D164Q37848281-3464656A-AF62-4EB2-A972-239639A2E45BQ38736870-70ADA5C1-D86C-476A-A86F-91EBA7BE9F01Q39017619-7EBCE9D9-3435-47FE-B753-AA269C3066BCQ40142473-5A2EC275-CAE0-43A7-983F-16FF7F89DFE4Q41020492-969FC49E-8CA8-4934-9082-02CBACB6EF48Q41206521-353DDA4D-220C-41E8-8CF8-E63561CCE36BQ42584897-CFF274AB-0B6C-46E9-8768-A8783A8A1FCCQ44887470-A66A54EC-09D1-4CB0-A48F-D0E8994A4E9FQ46337247-1D334CFD-74E8-4DCF-9C6C-A0F0F79F9E68Q47098282-7CFD2730-7356-41F1-B232-5C437CA61A2BQ50089879-99020C1C-4861-46BB-913C-345FFCA1CC18Q50929981-A852092E-02D7-4B03-B775-17F3B75A16F6Q51725776-03AACD7E-3B60-4EAF-AE08-50AD8A400297Q52382378-95D278BE-DE11-475F-8AFE-76C891488F50Q52759279-3671C6EA-709E-4234-A6E5-83ABFAF89160Q55295867-01840C1F-4C5A-4A46-815B-AAF7DE4EC3C2Q57162600-893A91CF-72A3-4A4D-BAA5-026BF2AFE3E1Q57933119-A5AD7632-F6C7-4592-A519-70E93F5A5843
P2860
Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of molecular dockin ...... inst dihydropteroate synthase.
@en
Validation of molecular dockin ...... inst dihydropteroate synthase.
@nl
type
label
Validation of molecular dockin ...... inst dihydropteroate synthase.
@en
Validation of molecular dockin ...... inst dihydropteroate synthase.
@nl
prefLabel
Validation of molecular dockin ...... inst dihydropteroate synthase.
@en
Validation of molecular dockin ...... inst dihydropteroate synthase.
@nl
P2093
P2860
P356
P1476
Validation of molecular dockin ...... inst dihydropteroate synthase.
@en
P2093
David M Ball
Jianjun Qi
Kerim Babaoglu
Stephen W White
P2860
P304
P356
10.1021/CI800293N
P577
2009-02-01T00:00:00Z